Nonprofit · EIN 95-4596354
TOWER CANCER RESEARCH FOUNDATION
Tax-exempt · BEVERLY HILLS, CA 90211
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $3,146,877 | $3,636,819 | -$489,942 | $3,237,640 | $2,031,926 | $1,205,714 |
| December 31, 2023 | 990 | $2,539,108 | $3,174,666 | -$635,558 | $3,927,785 | $2,492,756 | $1,435,029 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $3,653,482
- Program service revenue
- $0
- Investment income
- $49,288
- Net income from fundraising events
- -$555,893
- Other revenue
- -$555,893
Expenses
- Grants and similar amounts paid
- $889,920
- Compensation of officers, directors and key employees
- $319,785
- Other salaries and wages
- $880,087
- Salaries, compensation and benefits (total)
- $1,377,520
- Professional fundraising fees
- $0
- Legal fees
- $73,087
- Accounting fees
- $40,165
- Occupancy
- $556,894
- Depreciation
- $96,725
- Program services (functional)
- $2,508,236
- Management and general (functional)
- $389,917
- Fundraising (functional)
- $738,666
Balance sheet and other
- Total assets, start of year
- $3,927,785
- Total assets, end of year
- $3,237,640
- Total liabilities, end of year
- $2,031,926
- Net assets, end of year
- $1,205,714
- Land, buildings and equipment
- $102,709
- Publicly traded securities
- $1,959,201
- Net assets without donor restrictions
- $577,061
- Net assets with donor restrictions
- $628,653
- Gross receipts
- $3,840,815
- Employees
- 14
- Volunteers
- 0
- Year formed
- 1996
- State of legal domicile
- CA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| CHRISTOPHER CLINTON CONWAY | EXECUTIVE DIRECTOR Trustee or director, Officer | 40 | $280,777 | $14,810 |
| LINDA DAVID | EXECUTIVE DIRECTOR (THRU 1/5) Trustee or director, Officer | 40 | $9,050 | $0 |
| NANCY ROSENFELT | CHAIRMAN OF THE BOARD Trustee or director, Officer | 2 | $0 | $0 |
| LARRY ROSENSTEIN | VICE CHAIR Trustee or director, Officer | 2 | $0 | $0 |
| DONNA ROSEN | PAST CHAIRMAN OF THE BOARD Trustee or director, Officer | 2 | $0 | $0 |
| NANCY MISHKIN | PAST CHAIRMAN OF THE BOARD Trustee or director | 2 | $0 | $0 |
| DAVID SPINGARN | TREASURER Trustee or director, Officer | 2 | $0 | $0 |
| JEANNE SCHNITZER MARKS | SECRETARY Trustee or director, Officer | 2 | $0 | $0 |
| KELLY PRATHER | MAGNOLIA COUNCIL PRESIDENT Trustee or director | 2 | $0 | $0 |
| JONATHAN LAYNE | DEVELOPMENT COMMITTEE CHAI Trustee or director | 2 | $0 | $0 |
| SHELLEY WARSAVSKY | DIRECTOR Trustee or director | 2 | $0 | $0 |
| ELIZABETH DRUCKER | DIRECTOR Trustee or director | 2 | $0 | $0 |
| LINDA LEVENSON DELSACK | DIRECTOR Trustee or director | 2 | $0 | $0 |
| BETTY HAAGEN | DIRECTOR Trustee or director | 2 | $0 | $0 |
| RANDY KATZ | DIRECTOR Trustee or director | 2 | $0 | $0 |
10 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| BETH GOREN | DIRECTOR Trustee or director | 2 | $0 |
| SUSAN KREVOY PHD | DIRECTOR Trustee or director | 2 | $0 |
| FRANKIE SHOLEM | DIRECTOR Trustee or director | 2 | $0 |
| BARRY ROSENBLOOM MD | DIRECTOR Trustee or director | 2 | $0 |
| JOHN CARPTEN PHD | DIRECTOR Trustee or director | 2 | $0 |
| GEORGE RADDA | DIRECTOR Trustee or director | 2 | $0 |
| HOORA SADLER | DIRECTOR Trustee or director | 2 | $0 |
| JULIE SHAMES | DIRECTOR Trustee or director | 2 | $0 |
| KATHY SCOTT | DIRECTOR Trustee or director | 2 | $0 |
| PEGGY MILES | DIRECTOR Trustee or director | 2 | $0 |
990 for the year ended December 31, 2023: 31 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| STEVEN ABRAMSON | EXECUTIVE DIRECTOR (THRU 9/30/23) Trustee or director, Officer | 40 | $188,834 | $6,550 |
| KELLI SARGENT | DEPUTY DIRECTOR Highest-paid employee | 40 | $108,633 | $9,983 |
| LINDA DAVID | EXECUTIVE DIRECTOR Trustee or director, Officer | 40 | $51,417 | $0 |
| NANCY ROSENFELT | CHAIRMAN OF THE BOARD Trustee or director, Officer | 2 | $0 | $0 |
| LARRY ROSENSTEIN | VICE CHAIR Trustee or director, Officer | 2 | $0 | $0 |
| DONNA ROSEN | PAST CHAIRMAN OF THE BOARD Trustee or director, Officer | 2 | $0 | $0 |
| ABBY LEVY | PAST CHAIRMAN OF THE BOARD Trustee or director | 2 | $0 | $0 |
| NANCY MISHKIN | PAST CHAIRMAN OF THE BOARD Trustee or director | 2 | $0 | $0 |
| SOLOMON I HAMBURG MD PHD | PRESIDENT Trustee or director, Officer | 5 | $0 | $0 |
| DAVID SPINGARN | TREASURER Trustee or director, Officer | 2 | $0 | $0 |
| JEANNE SCHNITZER MARKS | SECRETARY Trustee or director, Officer | 2 | $0 | $0 |
| KELLY PRATHER | MAGNOLIA COUNCIL PRESIDENT Trustee or director | 2 | $0 | $0 |
| FRED ROSENFELT MD | VP SCIENTIFIC AFFAIRS Trustee or director | 2 | $0 | $0 |
| JONATHAN LAYNE | DEVELOPMENT COMMITTEE CHAI Trustee or director | 2 | $0 | $0 |
| SHELLEY WARSAVSKY | DIRECTOR Trustee or director | 2 | $0 | $0 |
| ELIZABETH DRUCKER | DIRECTOR Trustee or director | 2 | $0 | $0 |
| KAREN ROSENFELT BLANCATO | DIRECTOR Trustee or director | 2 | $0 | $0 |
| HILTON CHODOROW | DIRECTOR Trustee or director | 2 | $0 | $0 |
| ROBERT DECKER MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| LINDA LEVENSON DELSACK | DIRECTOR Trustee or director | 2 | $0 | $0 |
| BETTY HAAGEN | DIRECTOR Trustee or director | 2 | $0 | $0 |
| CASEY FEDERMAN | DIRECTOR Trustee or director | 2 | $0 | $0 |
| KATHY GALLAGHER | DIRECTOR Trustee or director | 2 | $0 | $0 |
| RANDY KATZ | DIRECTOR Trustee or director | 2 | $0 | $0 |
| BETH GOREN | DIRECTOR Trustee or director | 2 | $0 | $0 |
| SUSAN KREVOY PHD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| FRANKIE SHOLEM | DIRECTOR Trustee or director | 2 | $0 | $0 |
| SALLY MAGARAM | DIRECTOR Trustee or director | 2 | $0 | $0 |
| PHILOMENA MCANDREW MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| BARRY ROSENBLOOM MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| JOHN CARPTEN PHD | DIRECTOR Trustee or director | 2 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 8767 WILSHIRE BLVD SUITE 401, BEVERLY HILLS, CA 90211-2714
- In care of
- % SOLOMON I HAMBURG PRES
- Principal officer (990 for 2024)
- MATTHEW ZARCUFSKY CFRE, 8767 WILSHIRE BLVD 401, BEVERLY HILLS, CA 90211
- Signed the 990
- MATTHEW ZARCUFSKY CFRE, ED AND CPO
- Phone
- (310) 299-8470
- Website
- TOWERCANCER.ORG
- Return prepared by
- CLIFTONLARSONALLEN LLP
California records
California keeps its own records of charities and corporations. Search them by EIN 95-4596354 or by the name TOWER CANCER RESEARCH FOUNDATION.
- Attorney General, Registry of Charities and Fundraisers
- Registration status and filed reports (CT-TR-1, RRF-1)
- Secretary of State, bizfile Online
- Corporation status, entity number, agent for service
- Franchise Tax Board
- Entity status letter (state tax exemption, good standing)
Mission
THROUGH LOCAL INVESTMENTS, WE ADVANCE GROUNDBREAKING CANCER RESEARCH AND PROFOUNDLY SUPPORT PEOPLE AFFECTED BY THE DISEASE TO CREATE OUTSIZED IMPACT IN SOUTHERN CALIFORNIA AND BEYOND.
Program accomplishments
- IN 2023, TOWER FUNDED FOUR NEW CAREER DEVELOPMENT RESEARCH GRANTS FOR FOUR PROMISING YOUNG PHYSICIAN SCIENTISTS LOCATED AT UCLA, UCI AND UCSD. RESEARCH AREAS FOCUS ON INNOVATIVE THERAPIES SUCH AS: THE USE OF PH TO TARGET GLIOBLASTOMA CELLS IN HOPES TO IMPROVE TREATMENT FOR THIS DEADLY DISEASE; USING A MODEL OF SKIN CANCER, A NEW TOOL TO TRACK CANCER CELLS IN THEIR NATURAL HABITAT TO FIND HOW LYMPHATIC VESSELS SHIELD CANCER CELLS AND AID THEIR SPREAD TO OTHER PARTS OF THE BODY; TARGETING LIVER-METASTATIC PANCREATIC CANCER BY IDENTIFYING WEAKNESSES THAT CAN BE EXPLOITED TO SLOW THE GROWTH OF TUMORS IN THE LIVER OR POSSIBLY PREVENT THE ESTABLISHMENT OF METASTASIS FROM HAPPENING IN PANCREATIC CANCER; STEM CELL REPROGRAMMING OF ANTI-TUMOR T CELLS TO MAKE TIL THERAPY A MORE EFFECTIVE TREATMENT. IN ADDITION, TOWER CONTINUED FUNDING MUL-TI-YEAR SENIOR INVESTIGATOR GRANTS. TOTAL SCIENTIFIC GRANT EXPENDITURES IN 2023 TOPPED $700,000. INVESTING IN NOVEL IDEAS OF YOUNG INVESTIGATORS AND EXPERIENCED SENIOR INVESTIGATORS ALLOWS US TO LEVERAGE OUR DONOR DOLLARS TO HAVE MAXIMUM IMPACT. IN 2023 ALONE, TCRF RESEARCHERS REPORTED NEARLY $3M IN FOLLOW-ON FUNDING, DOZENS OF GRANTS, PUBLICATIONS ACADEMIC AWARDS, TWO CLINICAL TRIALS, AND SO MUCH MORE.OUR CLINICALLY-GROUNDED SURVIVORSHIP SUPPORT PROGRAMS, HOSTED BY MAGNOLIA HOUSE, ALIGN WITH THE CHALLENG-ES FACED BY PATIENTS, SURVIVORS, AND THE WHOLE CANCER COMMUNITY. WE PROVIDE INTEGRATIVE HEALTH AND WELL-NESS SUPPORT AND EDUCATION, THROUGH FREE FITNESS, THERAPEUTIC, AND HOLISTIC CLASSES, THAT EMPOWERPEOPLE TO DEVELOP A PHYSICAL AND EMOTIONAL TOOLKIT TO MEET THE CHALLENGES OF CANCER FROM DIAGNOSIS TO SURVIVORSHIP. IN 2023, TOWER INVESTED OVER $500,000 IN SURVIVORSHIP PROGRAMS. IN 2013, MAGNOLIA HOUSE SURVIVORSHIP SUPPORT PROGRAM OFFERED 20 CLASSES AND HAD 500 VISITS IN THE FIRST YEAR. IN 2023, MAGNOLIA HOUSE OFFERED OVER 1500 CLASSES/SERVICES AND RECEIVED OVER 20,000 PARTICIPANT VISITS. IN RESPONSE TO COVID19, WE CONTINUED OFFERING CLASSES ONLINE VIA ZOOM WHICH HAS EXPANDED THE DEMOGRAPHICS IN WHICH WE SERVICE AND ENABLED US TO INCREASE OUR CLASS CAPACITIES. WE ADDED OUTDOOR PROGRAMMING AT LOCAL PARKS WHICH HAVE BEEN WELL RECEIVED. EVEN WITH AN INCREASE IN CLASS CAPACITIES, MANY OF OUR CLASSES HAD A WAIT LIST WHICH HIGHLIGHTS BOTH THE QUALITY IN THE PROGRAMS WE OFFER AND THE VOID THAT EXISTS, ESPECIALLY WITH THE ISO-LATION MANY CANCER PATIENTS EXPERIENCE. PARTICIPANTS VIEW MAGNOLIA HOUSE SURVIVORSHIP SUPPORT PROGRAM AS A LIFELINE THAT PROVIDES NOT ONLY ENHANCED QUALITY OF LIFE BUT A COMMUNITY OF FRIENDSHIP, ENCOURAGEMENT, AND COMFORT AS WELL. ONE EXAMPLE THAT REFLECTS THE IMPACT OF MAGNOLIA HOUSE, IS THE SURVIVOR 2 THRIVER PEER TO PEER FUNDRAISING CAMPAIGN WE LAUNCHED IN THE SUMMER OF 2023. OUR GOAL WAS TO RAISE $5,000. MAGNOLIA HOUSE PARTICIPANTS RAISED $30,000 THROUGH THIS CAMPAIGN, HIGHLIGHTING THE DEPTH OF COMMUNITY AND IMPACT OF THE MAGNOLIA HOUSE PROGRAM.TOWER'S COMMUNITY PARTNERSHIP GRANT REVIEW COMMITTEE IS COMPOSED OF EXPERT VOLUNTEERS WHO REVIEW APPLICATIONS IN DEPTH AND THEN MEET TO DISCUSS GRANT APPLICATIONS FROM CANCER SUPPORT ORGANIZATIONS ACROSS SOUTHERN CALIFORNIA. IN 2023, WE FUNDED $200,000 IN COMMUNITY PARTNER GRANTS AND CONTINUED TO REFINE OUR REVIEW PROCESS WITH A NEW GRANT MANAGEMENT SYSTEM, NEW AND EXPERIENCED PEER GRANT REVIEWERS, AND A NEEDS ASSESSMENT TO REFLECT A MORE TARGETED FOCUS ON FUNDING ORGANIZATIONS THAT SUPPORT UNDERSERVED AND UNDER RESOURCED COMMUNITIES ALLOWING US TO EXTEND OUR SUPPORT TO THOSE MOST IN NEED OF CARE.Expenses $2,508,236 · grants $889,920
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 95-4596354
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1997
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H00Z)
- Assets (IRS master file)
- $3,237,640
- Income (IRS master file)
- $3,840,815
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $3,146,877 | $3,636,819 | $3,237,640 | XML |
| 990 | December 2023 | $2,539,108 | $3,174,666 | $3,927,785 | XML |
| 990 | December 2022 | $2,865,725 | $3,160,741 | $4,621,629 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2019 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 95-4596354).
Questions about TOWER CANCER RESEARCH FOUNDATION
- What is the EIN of TOWER CANCER RESEARCH FOUNDATION?
- The employer identification number (EIN) of TOWER CANCER RESEARCH FOUNDATION is 95-4596354.
- Is TOWER CANCER RESEARCH FOUNDATION tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1997.
- Are donations to TOWER CANCER RESEARCH FOUNDATION tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does TOWER CANCER RESEARCH FOUNDATION file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of TOWER CANCER RESEARCH FOUNDATION due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did TOWER CANCER RESEARCH FOUNDATION last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of TOWER CANCER RESEARCH FOUNDATION?
- The 990 for the year ended December 31, 2024 names MATTHEW ZARCUFSKY CFRE.
- Who are the officers and directors of TOWER CANCER RESEARCH FOUNDATION?
- The 990 for the year ended December 31, 2024 lists 25 people; 2 received compensation from the organization, the highest $280,777 (CHRISTOPHER CLINTON CONWAY, EXECUTIVE DIRECTOR).
- How much revenue does TOWER CANCER RESEARCH FOUNDATION have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $3,146,877, expenses of $3,636,819 and total assets of $3,237,640 at year end.
Other nonprofits in BEVERLY HILLS
- CALIFORNIA HEART CENTER FOUNDATION EIN 95-4772979 · last filed 990 for 2024
- NEUROSURGICAL ATLAS INC EIN 45-5167256 · last filed 990 for 2024
- LEEZA GIBBONS MEMORY FOUNDATION INC EIN 56-2356697 · last filed 990 for 2025
- DORDICK TRIAL COLLEGE 2 CORP EIN 92-2824784 · last filed 990-PF for 2024
- KERLAN-JOBE ORTHOPAEDIC FOUNDATION EIN 95-4707606 · last filed 990 for 2025
- WALLACE RHEUMATIC DISEASES FOUNDATION EIN 45-5434561 · last filed 990 for 2025
- ALL GREATER GOOD FOUNDATION EIN 87-0813455 · last filed 990 for 2024
- SOUTHERN CALIFORNIA LYMPHOMA GROUP INC EIN 91-2155575 · last filed 990-PF for 2025
All nonprofits in BEVERLY HILLS · California · Medical research